UTMD – Utah Medical Products, Inc.

UTMD — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.15

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

74.2

Target Price

65.23

Analyst Recom

Performance Q

7.42

Upside

-41.5%

Beta

0.38

Ticker: UTMD

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-09-25	UTMD	74.41	N/A	N/A	0
2026-09-28	UTMD	74.52	N/A	N/A	0
2026-09-29	UTMD	74.94	N/A	N/A	0
2026-09-30	UTMD	74.08	N/A	N/A	0
2026-10-01	UTMD	74.28	N/A	N/A	0
2026-10-02	UTMD	74.26	N/A	N/A	0
2026-10-05	UTMD	73.49	N/A	N/A	0
2026-10-06	UTMD	73.87	N/A	N/A	0
2026-10-07	UTMD	73.51	N/A	N/A	0
2026-10-08	UTMD	73.74	N/A	N/A	0
2026-10-09	UTMD	74.64	N/A	N/A	0
2026-10-12	UTMD	74.61	N/A	N/A	0
2026-10-13	UTMD	74.58	N/A	N/A	0
2026-10-14	UTMD	74.8	N/A	N/A	0
2026-10-15	UTMD	74.84	N/A	N/A	0
2026-10-16	UTMD	74.65	N/A	N/A	0
2026-10-19	UTMD	74.63	N/A	N/A	0
2026-10-20	UTMD	75.06	N/A	N/A	0
2026-10-21	UTMD	74.75	N/A	N/A	0
2026-10-22	UTMD	75.23	N/A	N/A	0
2026-10-23	UTMD	74.22	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-09-25	UTMD	74.24	-	-	-
2026-09-28	UTMD	74.53	-	-	-
2026-09-29	UTMD	74.80	-	-	-
2026-09-30	UTMD	74.12	-	-	-
2026-10-01	UTMD	74.32	-	-	-
2026-10-02	UTMD	74.13	-	-	-
2026-10-05	UTMD	73.45	-	-	-
2026-10-06	UTMD	73.94	-	-	-
2026-10-07	UTMD	73.45	-	-	-
2026-10-08	UTMD	73.88	-	-	-
2026-10-09	UTMD	74.76	-	-	-
2026-10-12	UTMD	74.33	-	-	-
2026-10-13	UTMD	74.57	-	-	-
2026-10-14	UTMD	74.64	-	-	-
2026-10-15	UTMD	74.76	-	-	-
2026-10-16	UTMD	74.61	-	-	-
2026-10-19	UTMD	74.63	-	-	-
2026-10-20	UTMD	74.63	-	-	-
2026-10-21	UTMD	75.08	-	-	-
2026-10-22	UTMD	75.07	-	-	-
2026-10-23	UTMD	74.20	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-09-25	UTMD	0.00	2.31	5.82
2026-09-28	UTMD	0.00	2.32	5.84
2026-09-29	UTMD	0.00	2.32	5.84
2026-09-30	UTMD	0.00	2.32	5.84
2026-10-01	UTMD	0.00	2.32	5.84
2026-10-02	UTMD	0.00	2.32	5.84
2026-10-05	UTMD	0.00	2.31	5.84
2026-10-06	UTMD	0.00	2.31	5.84
2026-10-07	UTMD	0.00	2.31	5.84
2026-10-08	UTMD	0.00	2.31	5.84
2026-10-09	UTMD	0.00	2.31	5.84
2026-10-12	UTMD	0.00	2.19	5.15
2026-10-13	UTMD	0.00	2.19	5.15
2026-10-14	UTMD	0.00	2.19	5.15
2026-10-15	UTMD	0.00	2.19	5.15
2026-10-16	UTMD	0.00	2.19	5.15
2026-10-19	UTMD	0.00	2.30	5.15
2026-10-20	UTMD	0.00	2.30	5.15
2026-10-21	UTMD	0.00	2.30	5.15
2026-10-22	UTMD	0.00	2.30	5.15
2026-10-23	UTMD	0.00	2.30	5.15
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

2.3

Beta

0.38

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

74.71

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

44.6

Max Drawdown 5-Year %

-55.6

Target Price

65.23

P/E

22.23

Forward P/E

PEG

P/S

6.75

P/B

1.91

P/Free Cash Flow

20.58

EPS

3.34

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

30.48

Relative Volume

1.03

Return on Equity vs Sector %

-17

Return on Equity vs Industry %

-1.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ UTMD Healthcare

$74.23

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

2/20

Pullback

13/25

Volume

4/15

Valuation

7/20

TP/AR

2/10

Options

0/10

RSI

51.2

Range 1M

26.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

6/30

Estimates

3/20

Inst/Vol

7/15

Options

0/10

EPS Yr

EPS NY

52W%

88%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -4.5% upside

Quality

8/30

Valuation

4/30

Growth

2/25

Stability

9/10

LT Trend

1/5

Upside

-4.5%

Quality

MoS

UTMD — P/E HistoricalMedical Instruments & Supplies

Utah Medical Products, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 140

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

UTMD

Latest News

—

Caricamento notizie per UTMD…

stock quote shares UTMD – Utah Medical Products, Inc. Stock Price stock today

news today UTMD – Utah Medical Products, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch UTMD – Utah Medical Products, Inc. yahoo finance google finance

stock history UTMD – Utah Medical Products, Inc. invest stock market

stock prices UTMD premarket after hours

ticker UTMD fair value insiders trading

ATRI – Atrion Corp.

ATRI — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.53

Margin Of Safety %

-2

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

459.92

Target Price

300

Analyst Recom

Performance Q

-2.64

Upside

N/A

Beta

0.69

Ticker: ATRI

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-09-25	ATRI	459.92	N/A	N/A	0
2026-09-28	ATRI	459.92	N/A	N/A	0
2026-09-29	ATRI	459.92	N/A	N/A	0
2026-09-30	ATRI	459.92	N/A	N/A	0
2026-10-01	ATRI	459.92	N/A	N/A	0
2026-10-02	ATRI	459.92	N/A	N/A	0
2026-10-05	ATRI	459.92	N/A	N/A	0
2026-10-06	ATRI	459.92	N/A	N/A	0
2026-10-07	ATRI	459.92	N/A	N/A	0
2026-10-08	ATRI	459.92	N/A	N/A	0
2026-10-09	ATRI	459.92	N/A	N/A	0
2026-10-12	ATRI	459.92	N/A	N/A	0
2026-10-13	ATRI	459.92	N/A	N/A	0
2026-10-14	ATRI	459.92	N/A	N/A	0
2026-10-15	ATRI	459.92	N/A	N/A	0
2026-10-16	ATRI	459.92	N/A	N/A	0
2026-10-19	ATRI	459.92	N/A	N/A	0
2026-10-20	ATRI	459.92	N/A	N/A	0
2026-10-21	ATRI	459.92	N/A	N/A	0
2026-10-22	ATRI	459.92	N/A	N/A	0
2026-10-23	ATRI	459.92	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

0.69

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

452.44

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

45.7

Max Drawdown 5-Year %

-66

Target Price

300

P/E

64.5

Forward P/E

PEG

P/S

4.46

P/B

3.39

P/Free Cash Flow

29.24

EPS

7.13

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.91

Relative Volume

Return on Equity vs Sector %

-18.1

Return on Equity vs Industry %

-3.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

No data found for ATRI

ATRI — P/E HistoricalMedical Instruments & Supplies

ATRI

Latest News

—

Caricamento notizie per ATRI…

stock quote shares ATRI – Atrion Corp. Stock Price stock today

news today ATRI – Atrion Corp. stock forecast ,stock prediction 2023 2024 2025

marketwatch ATRI – Atrion Corp. yahoo finance google finance

stock history ATRI – Atrion Corp. invest stock market

stock prices ATRI premarket after hours

ticker ATRI fair value insiders trading

ATR – Aptargroup Inc.

ATR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.35

Margin Of Safety %

Put/Call OI Ratio

0.56

EPS Next Q Diff

-0.02

EPS Last/This Y

-0.24

EPS This/Next Y

0.68

Price

126.55

Target Price

162

Analyst Recom

1.75

Performance Q

-5.11

Upside

-3.9%

Beta

0.34

Ticker: ATR

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-09-25	ATR	123.83	0.45	0.00	173
2026-09-28	ATR	124.44	0.45	0.00	175
2026-09-29	ATR	123.26	0.44	999.99	178
2026-09-30	ATR	121.14	0.45	999.99	180
2026-10-01	ATR	120.93	0.46	0.00	181
2026-10-02	ATR	120.02	0.46	0.00	181
2026-10-05	ATR	120.52	0.45	0.00	183
2026-10-06	ATR	120.25	0.45	999.99	183
2026-10-07	ATR	120.43	0.46	0.00	184
2026-10-08	ATR	121.8	0.46	0.01	184
2026-10-09	ATR	120.34	0.22	999.99	318
2026-10-12	ATR	118.92	0.22	999.99	319
2026-10-13	ATR	119.09	0.22	999.99	319
2026-10-14	ATR	120.28	0.23	0.00	321
2026-10-15	ATR	124.21	0.23	0.01	322
2026-10-16	ATR	124.48	0.19	0.00	409
2026-10-19	ATR	124.68	0.55	0.00	188
2026-10-20	ATR	125.8	0.55	999.99	189
2026-10-21	ATR	125.71	0.56	0.08	190
2026-10-22	ATR	128.09	0.52	0.00	202
2026-10-23	ATR	126.55	0.56	999.99	209
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-09-25	ATR	123.87	-8.6	52.9	5.52
2026-09-28	ATR	124.41	-8.6	53.1	5.52
2026-09-29	ATR	123.29	-8.6	46.4	5.52
2026-09-30	ATR	121.21	-8.6	42.7	5.52
2026-10-01	ATR	120.98	-8.6	50.3	5.52
2026-10-02	ATR	119.91	-8.6	46.0	5.51
2026-10-05	ATR	120.51	-8.6	53.5	5.51
2026-10-06	ATR	120.26	-8.6	49.6	5.51
2026-10-07	ATR	120.43	-8.6	51.7	5.51
2026-10-08	ATR	121.75	-8.6	56.4	5.51
2026-10-09	ATR	120.37	-8.8	45.2	5.51
2026-10-12	ATR	118.88	-8.8	44.9	5.51
2026-10-13	ATR	119.11	-9.0	51.6	5.51
2026-10-14	ATR	120.29	-9.0	55.4	5.51
2026-10-15	ATR	124.21	-9.0	71.5	5.51
2026-10-16	ATR	124.48	-9.0	51.9	5.51
2026-10-19	ATR	124.67	-9.0	31.6	5.51
2026-10-20	ATR	124.67	-9.0	31.6	5.51
2026-10-21	ATR	125.83	-9.1	35.6	5.50
2026-10-22	ATR	128.24	-9.1	40.9	5.50
2026-10-23	ATR	126.55	-9.1	24.8	5.50
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-09-25	ATR	-3.28	1.50	3.11
2026-09-28	ATR	-3.28	1.72	3.11
2026-09-29	ATR	-3.28	1.72	3.11
2026-09-30	ATR	-3.28	1.72	3.11
2026-10-01	ATR	-3.28	1.72	3.11
2026-10-02	ATR	-3.28	1.72	3.11
2026-10-05	ATR	-3.28	1.48	3.11
2026-10-06	ATR	-3.28	1.48	3.11
2026-10-07	ATR	-3.31	1.48	3.11
2026-10-08	ATR	-3.31	1.48	3.11
2026-10-09	ATR	-3.31	1.48	3.11
2026-10-12	ATR	-3.31	1.61	3.35
2026-10-13	ATR	-3.31	1.61	3.35
2026-10-14	ATR	-3.31	1.61	3.35
2026-10-15	ATR	-3.31	1.61	3.35
2026-10-16	ATR	-3.31	1.61	3.35
2026-10-19	ATR	-3.31	1.57	3.35
2026-10-20	ATR	-3.31	1.57	3.35
2026-10-21	ATR	-3.31	1.57	3.35
2026-10-22	ATR	-3.31	1.57	3.35
2026-10-23	ATR	-3.31	1.57	3.35
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.42

Avg. EPS Est. Current Quarter

1.47

Avg. EPS Est. Next Quarter

1.4

Insider Transactions

-3.31

Institutional Transactions

1.57

Beta

0.34

Average Sales Estimate Current Quarter

982

Average Sales Estimate Next Quarter

979

Fair Value

143.89

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

28.9

Max Drawdown 5-Year %

-35.2

Target Price

162

P/E

22.86

Forward P/E

20.49

PEG

3.32

P/S

2.05

P/B

3.06

P/Free Cash Flow

25.92

EPS

5.53

Average EPS Est. Cur. Y

5.5

EPS Next Y. (Est.)

6.18

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.22

Relative Volume

0.77

Return on Equity vs Sector %

-11.8

Return on Equity vs Industry %

4.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

24.8

◆ ATR Healthcare

$126.55

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

14/20

Pullback

10/25

Volume

9/15

Valuation

16/20

TP/AR

1/10

Options

4/10

RSI

58.2

Range 1M

80.6%

Sup Dist

0.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

9/30

Estimates

6/20

Inst/Vol

3/15

Options

6/10

EPS Yr

-4.3%

EPS NY

12.4%

52W%

53.8%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +13.4% upside

Quality

9/30

Valuation

7/30

Growth

8/25

Stability

8/10

LT Trend

2/5

Upside

+13.4%

Quality

MoS

14%

ATR — P/E HistoricalPackaging & Containers

AptarGroup, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 14000

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

ATR

Latest News

—

Caricamento notizie per ATR…

stock quote shares ATR – Aptargroup Inc. Stock Price stock today

news today ATR – Aptargroup Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ATR – Aptargroup Inc. yahoo finance google finance

stock history ATR – Aptargroup Inc. invest stock market

stock prices ATR premarket after hours

ticker ATR fair value insiders trading

ANIK – Anika Therapeutics Inc.

ANIK — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.93

Margin Of Safety %

Put/Call OI Ratio

1.24

EPS Next Q Diff

-0.11

EPS Last/This Y

0.94

EPS This/Next Y

-0.1

Price

21.42

Target Price

Analyst Recom

Performance Q

42.61

Upside

-116.4%

Beta

0.22

Ticker: ANIK

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-09-25	ANIK	20.41	4.12	0.00	901
2026-09-28	ANIK	20.67	4.12	0.00	901
2026-09-29	ANIK	19.93	4.12	0.00	901
2026-09-30	ANIK	19.64	3.98	999.99	907
2026-10-01	ANIK	19.37	3.98	999.99	907
2026-10-02	ANIK	19.13	3.98	999.99	907
2026-10-05	ANIK	19.65	3.98	999.99	907
2026-10-06	ANIK	19.15	3.98	999.99	907
2026-10-07	ANIK	19.54	3.98	999.99	907
2026-10-08	ANIK	19.22	3.99	999.99	908
2026-10-09	ANIK	19.54	3.99	999.99	908
2026-10-12	ANIK	20.58	3.99	999.99	908
2026-10-13	ANIK	20.51	4.01	6.00	912
2026-10-14	ANIK	20.21	4.02	2.00	919
2026-10-15	ANIK	20.69	4.02	2.00	919
2026-10-16	ANIK	20.01	4.01	0.00	921
2026-10-19	ANIK	20.21	4.01	0.00	921
2026-10-20	ANIK	20.48	1.27	0.00	413
2026-10-21	ANIK	20.58	1.24	0.00	417
2026-10-22	ANIK	21.06	1.24	0.00	417
2026-10-23	ANIK	21.42	1.24	0.00	417
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-09-25	ANIK	20.42	325.0	-	1.05
2026-09-28	ANIK	20.63	325.0	-	1.05
2026-09-29	ANIK	19.95	325.0	-	1.05
2026-09-30	ANIK	19.69	325.0	-	1.05
2026-10-01	ANIK	19.34	325.0	-	1.05
2026-10-02	ANIK	19.10	325.0	-	1.05
2026-10-05	ANIK	19.74	325.0	-	1.05
2026-10-06	ANIK	19.11	325.0	-	1.05
2026-10-07	ANIK	19.53	325.0	-	1.05
2026-10-08	ANIK	19.20	325.0	-	1.05
2026-10-09	ANIK	19.56	950.0	-	1.05
2026-10-12	ANIK	20.48	950.0	-	1.05
2026-10-13	ANIK	20.44	950.0	-	1.05
2026-10-14	ANIK	20.26	950.0	-	1.05
2026-10-15	ANIK	20.67	950.0	-	1.05
2026-10-16	ANIK	20.01	950.0	-	1.05
2026-10-19	ANIK	20.28	950.0	-	1.05
2026-10-20	ANIK	20.28	950.0	-	1.05
2026-10-21	ANIK	20.45	950.0	-	1.05
2026-10-22	ANIK	21.09	950.0	-	1.05
2026-10-23	ANIK	21.42	950.0	-	1.05
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-09-25	ANIK	2.34	-0.93	3.04
2026-09-28	ANIK	2.34	-0.89	3.04
2026-09-29	ANIK	2.34	-0.89	3.04
2026-09-30	ANIK	2.34	-0.89	3.04
2026-10-01	ANIK	2.34	-0.89	3.04
2026-10-02	ANIK	2.34	-0.89	3.04
2026-10-05	ANIK	2.34	-0.88	3.04
2026-10-06	ANIK	2.34	-0.88	3.04
2026-10-07	ANIK	2.34	-0.88	3.04
2026-10-08	ANIK	2.34	-0.88	3.04
2026-10-09	ANIK	2.34	-0.88	3.04
2026-10-12	ANIK	2.34	-0.73	2.93
2026-10-13	ANIK	2.34	-0.73	2.93
2026-10-14	ANIK	2.34	-0.73	2.93
2026-10-15	ANIK	2.34	-0.73	2.93
2026-10-16	ANIK	2.34	-0.73	2.93
2026-10-19	ANIK	2.34	-0.66	2.93
2026-10-20	ANIK	2.34	-0.66	2.93
2026-10-21	ANIK	2.34	-0.66	2.93
2026-10-22	ANIK	2.34	-0.66	2.93
2026-10-23	ANIK	2.34	-0.66	2.93
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.3

Avg. EPS Est. Current Quarter

0.42

Avg. EPS Est. Next Quarter

0.19

Insider Transactions

2.34

Institutional Transactions

-0.66

Beta

0.22

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

53.2

Max Drawdown 5-Year %

-82

Target Price

P/E

Forward P/E

22.55

PEG

0.19

P/S

2.38

P/B

2.09

P/Free Cash Flow

511.9

EPS

-0.27

Average EPS Est. Cur. Y

1.05

EPS Next Y. (Est.)

0.95

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.14

Relative Volume

0.55

Return on Equity vs Sector %

-28.4

Return on Equity vs Industry %

-8.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ ANIK Healthcare

$21.42

📉

Swing / Pullback

Buy the dip on strong trends

WATCH

Trend

20/20

Pullback

8/25

Volume

11/15

Valuation

9/20

TP/AR

4/10

Options

4/10

RSI

61.5

Range 1M

100%

Sup Dist

4.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

22/30

Estimates

3/20

Inst/Vol

4/15

Options

2/10

EPS Yr

854.6%

EPS NY

-9.5%

52W%

89.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -28.1% upside

Quality

7/30

Valuation

6/30

Growth

15/25

Stability

8/10

LT Trend

4/5

Upside

-28.1%

Quality

ANIK — P/E HistoricalBiotechnology

Anika Therapeutics Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 235

Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation. It also provides Integrity, an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; non-orthopedic products, including Hyvisc, a high molecular weight injectable HA veterinary product for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine OA; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and ophthalmic products; and Anikavisc and Nuvisc high molecular weight HA products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

ANIK

Latest News

—

Caricamento notizie per ANIK…

stock quote shares ANIK – Anika Therapeutics Inc. Stock Price stock today

news today ANIK – Anika Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ANIK – Anika Therapeutics Inc. yahoo finance google finance

stock history ANIK – Anika Therapeutics Inc. invest stock market

stock prices ANIK premarket after hours

ticker ANIK fair value insiders trading

ANGO – Angiodynamic Inc

ANGO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.48

Margin Of Safety %

-13

Put/Call OI Ratio

0.3

EPS Next Q Diff

-0.05

EPS Last/This Y

-0.13

EPS This/Next Y

0.17

Price

12.36

Target Price

18.33

Analyst Recom

Performance Q

-9.48

Upside

-323.7%

Beta

0.28

Ticker: ANGO

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-09-25	ANGO	15.49	0.84	3.64	1466
2026-09-28	ANGO	15.55	0.84	0.19	1481
2026-09-29	ANGO	15.6	0.82	0.01	1514
2026-09-30	ANGO	15.37	0.75	0.00	1596
2026-10-01	ANGO	15.12	0.67	0.19	1709
2026-10-02	ANGO	15.11	0.64	16.50	1763
2026-10-05	ANGO	15.55	0.67	0.00	1794
2026-10-06	ANGO	14.43	0.69	1.48	1754
2026-10-07	ANGO	14.16	0.70	0.69	1836
2026-10-08	ANGO	11.21	0.63	0.07	2114
2026-10-09	ANGO	11.52	0.45	0.01	2583
2026-10-12	ANGO	11.48	0.44	0.00	2599
2026-10-13	ANGO	10.89	0.41	999.99	2556
2026-10-14	ANGO	11.05	0.41	0.00	2547
2026-10-15	ANGO	11.59	0.39	0.00	2536
2026-10-16	ANGO	11.26	0.39	0.21	2551
2026-10-19	ANGO	11.39	0.30	0.00	908
2026-10-20	ANGO	11.81	0.30	0.00	908
2026-10-21	ANGO	11.9	0.31	0.00	885
2026-10-22	ANGO	12.02	0.30	0.00	900
2026-10-23	ANGO	12.36	0.30	0.00	899
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-09-25	ANGO	15.51	-13.3	-	-0.27
2026-09-28	ANGO	15.56	-13.3	-	-0.27
2026-09-29	ANGO	15.59	-13.3	-	-0.27
2026-09-30	ANGO	15.38	-13.3	-	-0.27
2026-10-01	ANGO	15.11	-13.3	-	-0.27
2026-10-02	ANGO	15.11	-13.3	-	-0.27
2026-10-05	ANGO	15.53	-13.3	-	-0.27
2026-10-06	ANGO	14.43	-13.3	-	-0.27
2026-10-07	ANGO	14.18	-13.3	-	-0.27
2026-10-08	ANGO	11.22	-13.3	-	-0.27
2026-10-09	ANGO	11.51	-13.3	-	-0.27
2026-10-12	ANGO	11.40	-13.3	-	-0.27
2026-10-13	ANGO	10.90	-13.3	-	-0.27
2026-10-14	ANGO	11.06	-13.3	-	-0.27
2026-10-15	ANGO	11.59	-13.3	-	-0.27
2026-10-16	ANGO	11.25	0.0	-	-0.28
2026-10-19	ANGO	11.39	0.0	-	-0.28
2026-10-20	ANGO	11.39	0.0	-	-0.28
2026-10-21	ANGO	11.81	0.0	-	-0.28
2026-10-22	ANGO	12.04	0.0	-	-0.28
2026-10-23	ANGO	12.36	0.0	-	-0.28
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-09-25	ANGO	-0.49	-2.19	3.67
2026-09-28	ANGO	-0.49	-2.21	3.67
2026-09-29	ANGO	-0.49	-2.21	3.67
2026-09-30	ANGO	-0.49	-2.21	3.67
2026-10-01	ANGO	-0.49	-2.21	3.67
2026-10-02	ANGO	-0.48	-2.21	3.61
2026-10-05	ANGO	-0.48	-2.19	3.61
2026-10-06	ANGO	-0.48	-2.19	3.61
2026-10-07	ANGO	-0.48	-2.19	3.61
2026-10-08	ANGO	-0.48	-2.19	3.61
2026-10-09	ANGO	-0.48	-2.19	3.61
2026-10-12	ANGO	-0.48	-1.99	3.48
2026-10-13	ANGO	-0.48	-1.99	3.48
2026-10-14	ANGO	-0.48	-1.99	3.48
2026-10-15	ANGO	-0.48	-1.99	3.48
2026-10-16	ANGO	-0.48	-1.99	3.48
2026-10-19	ANGO	-0.48	-2.02	3.48
2026-10-20	ANGO	-0.48	-2.02	3.48
2026-10-21	ANGO	-0.48	-2.02	3.48
2026-10-22	ANGO	-0.48	-2.02	3.48
2026-10-23	ANGO	-0.48	-2.02	3.48
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.04

Avg. EPS Est. Current Quarter

-0.07

Avg. EPS Est. Next Quarter

-0.09

Insider Transactions

-0.48

Institutional Transactions

-2.02

Beta

0.28

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

10.79

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

61.4

Max Drawdown 5-Year %

-83

Target Price

18.33

P/E

Forward P/E

PEG

P/S

1.6

P/B

3.2

P/Free Cash Flow

EPS

-0.79

Average EPS Est. Cur. Y

-0.28

EPS Next Y. (Est.)

-0.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-10.12

Relative Volume

Return on Equity vs Sector %

-45.7

Return on Equity vs Industry %

-29.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

◆ ANGO Healthcare

$12.36

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

17/25

Volume

1/15

Valuation

14/20

TP/AR

4/10

Options

5/10

RSI

41.7

Range 1M

32.9%

Sup Dist

4.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

19/30

Estimates

4/20

Inst/Vol

2/15

Options

7/10

EPS Yr

-82%

EPS NY

61.6%

52W%

42.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +11.7% upside

Quality

5/30

Valuation

7/30

Growth

14/25

Stability

8/10

LT Trend

0/5

Upside

+11.7%

Quality

MoS

-13%

ANGO — P/E HistoricalMedical Instruments & Supplies

AngioDynamics, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 632

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

ANGO

Latest News

—

Caricamento notizie per ANGO…

stock quote shares ANGO – Angiodynamic Inc Stock Price stock today

news today ANGO – Angiodynamic Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ANGO – Angiodynamic Inc yahoo finance google finance

stock history ANGO – Angiodynamic Inc invest stock market

stock prices ANGO premarket after hours

ticker ANGO fair value insiders trading

BLCO – Bausch + Lomb Corporation

BLCO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.61

Margin Of Safety %

Put/Call OI Ratio

0.16

EPS Next Q Diff

0.19

EPS Last/This Y

0.3

EPS This/Next Y

0.31

Price

17.47

Target Price

18.64

Analyst Recom

2.36

Performance Q

Upside

N/A

Beta

0.55

Ticker: BLCO

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-09-25	BLCO	16.86	0.05	1.15	4871
2026-09-28	BLCO	16.98	0.07	0.18	4962
2026-09-29	BLCO	17.13	0.07	0.00	5083
2026-09-30	BLCO	17	0.07	0.02	5163
2026-10-01	BLCO	16.94	0.07	0.00	5199
2026-10-02	BLCO	17.1	0.07	0.01	5369
2026-10-05	BLCO	17.19	0.06	1.03	5566
2026-10-06	BLCO	17.2	0.07	0.41	5636
2026-10-07	BLCO	17.36	0.08	0.00	5695
2026-10-08	BLCO	17.13	0.08	0.24	5705
2026-10-09	BLCO	17.31	0.08	0.00	5757
2026-10-12	BLCO	16.07	0.08	0.77	5788
2026-10-13	BLCO	15.8	0.13	0.13	6476
2026-10-14	BLCO	16.02	0.13	0.14	6913
2026-10-15	BLCO	16.68	0.13	0.02	7106
2026-10-16	BLCO	16.46	0.13	0.04	7222
2026-10-19	BLCO	16.62	0.18	0.01	4006
2026-10-20	BLCO	16.9	0.17	0.00	4347
2026-10-21	BLCO	17.17	0.17	0.03	4394
2026-10-22	BLCO	17.44	0.16	0.01	4588
2026-10-23	BLCO	17.46	0.16	0.00	4662
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-09-25	BLCO	16.86	20.5	-	0.81
2026-09-28	BLCO	16.96	20.5	-	0.81
2026-09-29	BLCO	17.15	20.5	-	0.81
2026-09-30	BLCO	17.00	20.5	-	0.81
2026-10-01	BLCO	16.94	20.5	-	0.81
2026-10-02	BLCO	17.11	20.5	-	0.81
2026-10-05	BLCO	17.17	20.5	-	0.81
2026-10-06	BLCO	17.19	20.5	-	0.81
2026-10-07	BLCO	17.34	20.5	-	0.81
2026-10-08	BLCO	17.15	20.5	-	0.81
2026-10-09	BLCO	17.32	21.7	-	0.81
2026-10-12	BLCO	16.08	21.7	-	0.81
2026-10-13	BLCO	15.82	22.1	-	0.81
2026-10-14	BLCO	16.05	22.1	-	0.81
2026-10-15	BLCO	16.69	22.1	-	0.81
2026-10-16	BLCO	16.48	22.1	-	0.81
2026-10-19	BLCO	16.60	22.1	-	0.81
2026-10-20	BLCO	16.60	22.1	-	0.81
2026-10-21	BLCO	16.92	22.1	96.2	0.81
2026-10-22	BLCO	17.43	22.1	98.4	0.81
2026-10-23	BLCO	17.47	22.1	95.5	0.81
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

Last Quarter Act. EPS

0.16

Avg. EPS Est. Current Quarter

0.22

Avg. EPS Est. Next Quarter

0.35

Insider Transactions

0.02

Institutional Transactions

-1.04

Beta

0.55

Average Sales Estimate Current Quarter

1370

Average Sales Estimate Next Quarter

1485

Fair Value

20.55

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

20.4

Max Drawdown 5-Year %

Target Price

18.64

P/E

Forward P/E

15.51

PEG

0.38

P/S

1.13

P/B

0.94

P/Free Cash Flow

42.82

EPS

-0.48

Average EPS Est. Cur. Y

0.81

EPS Next Y. (Est.)

1.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.21

Relative Volume

0.9

Return on Equity vs Sector %

-28.3

Return on Equity vs Industry %

-12.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

95.5

No data found for BLCO

BLCO — P/E HistoricalMedical Instruments & Supplies

Bausch + Lomb Corporation

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 13000

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

BLCO

Latest News

—

Caricamento notizie per BLCO…

stock quote shares BLCO – Bausch + Lomb Corporation Stock Price stock today

news today BLCO – Bausch + Lomb Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch BLCO – Bausch + Lomb Corporation yahoo finance google finance

stock history BLCO – Bausch + Lomb Corporation invest stock market

stock prices BLCO premarket after hours

ticker BLCO fair value insiders trading

No more stocks to show

UTMD – Utah Medical Products, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: UTMD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

ATRI – Atrion Corp.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ATRI

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y